ArticleCancer innovation2022

ATF4/TXNIP/REDD1/mTOR signaling mediates the antitumor activities of liver X receptor in pancreatic cancers.

Zhikang Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.